<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1255-589'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/profile/">Profile</a>
<span>Breast Cancer Monitor Panel (CA 15-3, CEA) </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">Breast Cancer Monitor Panel (CA 15-3, CEA) </h1>
<div class="post-text">
<p>Breast cancer is one of the most common cancers affecting women worldwide. Early detection and monitoring of the disease are crucial for improving outcomes and survival rates. The Breast Cancer Monitor Panel, which includes CA 15-3 and CEA tests, is an important tool in monitoring the progress of breast cancer treatment and checking for recurrence. </p>
<p>CA 15-3 is a protein that is elevated in many individuals with breast cancer. CEA, or carcinoembryonic antigen, is another protein that can be elevated in various types of cancer, including breast cancer. Monitoring the levels of these markers can help healthcare professionals to evaluate how well the body is responding to treatment for breast cancer. </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Profile Name</th>
			<td scope="col">Breast Cancer Monitor Panel (CA 15-3, CEA) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Blood </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No fasting or special preparation is required before the test. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>4 hours </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td> â‚¹ 2150 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3">What is the Breast Cancer Monitor Panel?</h2>
<p>The Breast Cancer Monitor Panel is a blood test that measures the levels of two markers, CA 15-3 and CEA, which can be elevated in individuals with breast cancer.</p>
<h2 class="test-h2 mt-3">Who should get the Breast Cancer Monitor Panel?</h2>
<p>Individuals diagnosed with breast cancer, especially those undergoing treatment, should get this test. It can be used to monitor the effectiveness of treatment and check for cancer recurrence.</p>
<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
<h2 class="test-h2 mt-3">How is the Breast Cancer Monitor Panel performed?</h2>
<p>A healthcare professional will draw a blood sample from a vein in your arm, which is then sent to a laboratory for analysis.</p>
<h2 class="test-h2 mt-3">What does a high level of CA 15-3 or CEA indicate?</h2>
<p>High levels of CA 15-3 or CEA can indicate the presence of breast cancer. However, levels can also be elevated due to other conditions. Your doctor will interpret the results in the context of your overall health and other test results.</p>
<h2 class="test-h2 mt-3">Can the Breast Cancer Monitor Panel be used for early detection of breast cancer?</h2>
<p>No, this panel is not used for screening or early detection of breast cancer. It is used primarily for monitoring purposes in individuals who have already been diagnosed with breast cancer.</p>
<h2 class="test-h2 mt-3">How often should this panel be done?</h2>
<p>The frequency of testing depends on the stage of breast cancer and the treatment plan. Your doctor will recommend how often you should have this test.</p>
<h2 class="test-h2 mt-3">Are there any factors that can affect the levels of CA 15-3 and CEA?</h2>
<p>Yes, levels of CA 15-3 and CEA can be affected by liver disease, inflammation, and other types of cancer.</p>
<h2 class="test-h2 mt-3">What should I do if my levels of CA 15-3 or CEA are elevated?</h2>
<p>It is important to discuss the results with your doctor, who will interpret them in the context of your overall health and may recommend further tests or adjustments to your treatment plan.</p>
<h2 class="test-h2 mt-3">Can men get the Breast Cancer Monitor Panel?</h2>
<p>Yes, men can also develop breast cancer, although it is less common. Men diagnosed with breast cancer may also be monitored using this panel.</p>
<h2 class="test-h2 mt-3"> Can the levels of CA 15-3 and CEA return to normal after successful treatment?</h2>
<p>Yes, levels of CA 15-3 and CEA can decrease and return to normal levels after successful treatment of breast cancer.</p>
<h2 class="test-h2 mt-3"> Is the Breast Cancer Monitor Panel used alone for monitoring breast cancer?</h2>
<p>No, it is usually used in conjunction with other tests and examinations as part of a comprehensive monitoring strategy.</p>
<h2 class="test-h2 mt-3"> What is the difference between CA 15-3 and CEA?</h2>
<p>CA 15-3 is a marker that is more specific to breast cancer, while CEA can be elevated in various types of cancer including breast, colon, and lung cancer.</p>
<h2 class="test-h2 mt-3"> Can benign breast conditions affect CA 15-3 or CEA levels?</h2>
<p>Yes, some benign breast conditions and even some non-breast-related conditions can cause elevated CA 15-3 or CEA levels.</p>
<h2 class="test-h2 mt-3"> Are there any alternatives to the Breast Cancer Monitor Panel for monitoring breast cancer?</h2>
<p>There are other markers and tests that can be used for monitoring breast cancer, such as CA 27.29 and regular imaging studies. Your doctor will determine the best monitoring strategy for your case.</p>
<h2 class="test-h2 mt-3"> Which doctor should I consult if I have abnormal levels of CA 15-3 or CEA?</h2>
<p>You should consult your doctor who is handling your breast cancer treatment. They may refer you to an oncologist if you are not already seeing one.</p>
<p>Monitoring breast cancer is an integral part of managing the disease. The Breast Cancer Monitor Panel, which includes CA 15-3 and CEA tests, helps in assessing the response to treatment and in the early detection of recurrence. Regular monitoring, along with adherence to treatment plans and maintaining communication with your healthcare team, can contribute significantly to managing breast cancer effectively.</p>

</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>
